Aurora Cannabis Inc. is a leading company in the cannabis industry, primarily focused on the production and distribution of medical and recreational cannabis products. With a commitment to sustainability and innovation, the company cultivates a diverse range of cannabis strains and products, including dried flower, oils, and edibles, aimed at meeting the demands of consumers and patients alike. Aurora operates through a network of facilities and has established a strong presence in multiple international markets, working to advance the understanding and benefits of cannabis through research and development. The company is dedicated to promoting responsible usage and prioritizes quality and compliance within its operations. Read More
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug.
Georgia lawmakers are reviewing the future of hemp and marijuana products in the state, and opinions are sharply divided. During a recent legislative study committee meeting, people from both sides of the debate shared their experiences and concerns, laying the groundwork for possible policy updates in the state.
Georgia lawmakers are reviewing the future of hemp and marijuana products in the state, and opinions are sharply divided. During a recent legislative study committee meeting, people from both sides of the debate shared their experiences and concerns, laying the groundwork for possible policy updates in the state.
Emergency rooms across Canada are seeing a significant increase in visits from marijuana users suffering from repeated, severe vomiting—a condition called cannabis hyperemesis syndrome (CHS). According to a recent study, cases of CHS have grown thirteenfold over an eight-year period, making up over 8,000 of nearly 13,000 marijuana-related ER visits during that time.
Emergency rooms across Canada are seeing a significant increase in visits from marijuana users suffering from repeated, severe vomiting—a condition called cannabis hyperemesis syndrome (CHS). According to a recent study, cases of CHS have grown thirteenfold over an eight-year period, making up over 8,000 of nearly 13,000 marijuana-related ER visits during that time.
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
A new poll shows that most Texas voters are not in favor of a full ban on hemp-based THC products. The survey revealed that 53% of voters were against the ban that state lawmakers had passed under SB 3. In contrast, just 31% said they were in favor of it.
A new poll shows that most Texas voters are not in favor of a full ban on hemp-based THC products. The survey revealed that 53% of voters were against the ban that state lawmakers had passed under SB 3. In contrast, just 31% said they were in favor of it.
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK CITY, NY / ACCESS Newswire / June 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ:ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK CITY, NY / ACCESS Newswire / June 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ:ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK CITY, NY / ACCESS Newswire / June 25, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ:ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK CITY, NY / ACCESS Newswire / June 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ:ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
